117 related articles for article (PubMed ID: 28136132)
1. R-warfarin clearances from plasma associated with polymorphic cytochrome P450 2C19 and simulated by individual physiologically based pharmacokinetic models for 11 cynomolgus monkeys.
Utoh M; Kusama T; Miura T; Mitsui M; Kawano M; Hirano T; Shimizu M; Uno Y; Yamazaki H
Xenobiotica; 2018 Feb; 48(2):206-210. PubMed ID: 28136132
[TBL] [Abstract][Full Text] [Related]
2. Slow R-warfarin 7-hydroxylation mediated by P450 2C19 genetic variants in cynomolgus monkeys in vivo.
Utoh M; Yoshikawa T; Hayashi Y; Shimizu M; Iwasaki K; Uno Y; Yamazaki H
Biochem Pharmacol; 2015 May; 95(2):110-4. PubMed ID: 25801008
[TBL] [Abstract][Full Text] [Related]
3. Association with polymorphic marmoset cytochrome P450 2C19 of in vivo hepatic clearances of chirally separated R-omeprazole and S-warfarin using individual marmoset physiologically based pharmacokinetic models.
Kusama T; Toda A; Shimizu M; Uehara S; Inoue T; Uno Y; Utoh M; Sasaki E; Yamazaki H
Xenobiotica; 2018 Oct; 48(10):1072-1077. PubMed ID: 29034770
[TBL] [Abstract][Full Text] [Related]
4. Efavirenz clearances in vitro and in vivo in six cynomolgus monkeys associated with polymorphic cytochrome P450 2C9 and simulated by individual physiologically based pharmacokinetic models.
Utoh M; Miura T; Kusama T; Uehara S; Shimizu M; Uno Y; Yamazaki H
Biopharm Drug Dispos; 2017 Oct; 38(7):439-442. PubMed ID: 28608515
[TBL] [Abstract][Full Text] [Related]
5. Oxidation of R- and S-omeprazole stereoselectively mediated by liver microsomal cytochrome P450 2C19 enzymes from cynomolgus monkeys and common marmosets.
Uehara S; Kawano M; Murayama N; Uno Y; Utoh M; Inoue T; Sasaki E; Yamazaki H
Biochem Pharmacol; 2016 Nov; 120():56-62. PubMed ID: 27641812
[TBL] [Abstract][Full Text] [Related]
6. Human plasma concentrations of cytochrome P450 probes extrapolated from pharmacokinetics in cynomolgus monkeys using physiologically based pharmacokinetic modeling.
Shida S; Utoh M; Murayama N; Shimizu M; Uno Y; Yamazaki H
Xenobiotica; 2015; 45(10):881-6. PubMed ID: 26075833
[TBL] [Abstract][Full Text] [Related]
7. Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole and metoprolol in cynomolgus monkeys using in vitro-in vivo correlation.
Koyanagi T; Nakanishi Y; Murayama N; Yamaura Y; Ikeda K; Yano K; Uehara S; Utoh M; Kim S; Uno Y; Yamazaki H
Xenobiotica; 2015 Apr; 45(4):312-21. PubMed ID: 25364857
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of drug-metabolizing cytochrome P450 enzymes in cynomolgus and rhesus monkeys and common marmosets in preclinical studies for humans.
Uno Y; Uehara S; Yamazaki H
Biochem Pharmacol; 2018 Jul; 153():184-195. PubMed ID: 29277691
[TBL] [Abstract][Full Text] [Related]
9. Individual Differences in Metabolic Clearance of S-Warfarin Efficiently Mediated by Polymorphic Marmoset Cytochrome P450 2C19 in Livers.
Uehara S; Uno Y; Inoue T; Kawano M; Shimizu M; Toda A; Utoh M; Sasaki E; Yamazaki H
Drug Metab Dispos; 2016 Jul; 44(7):911-5. PubMed ID: 27098744
[TBL] [Abstract][Full Text] [Related]
10. Effects of aging and rifampicin pretreatment on the pharmacokinetics of human cytochrome P450 probes caffeine, warfarin, omeprazole, metoprolol and midazolam in common marmosets genotyped for cytochrome P450 2C19.
Toda A; Uehara S; Inoue T; Utoh M; Kusama T; Shimizu M; Uno Y; Mogi M; Sasaki E; Yamazaki H
Xenobiotica; 2018 Jul; 48(7):720-726. PubMed ID: 28686070
[TBL] [Abstract][Full Text] [Related]
11. Monkey liver cytochrome P450 2C19 is involved in R- and S-warfarin 7-hydroxylation.
Hosoi Y; Uno Y; Murayama N; Fujino H; Shukuya M; Iwasaki K; Shimizu M; Utoh M; Yamazaki H
Biochem Pharmacol; 2012 Dec; 84(12):1691-5. PubMed ID: 23041648
[TBL] [Abstract][Full Text] [Related]
12. Similar substrate specificity of cynomolgus monkey cytochrome P450 2C19 to reported human P450 2C counterpart enzymes by evaluation of 89 drug clearances.
Hosaka S; Murayama N; Satsukawa M; Uehara S; Shimizu M; Iwasaki K; Iwano S; Uno Y; Yamazaki H
Biopharm Drug Dispos; 2015 Dec; 36(9):636-43. PubMed ID: 26348733
[TBL] [Abstract][Full Text] [Related]
13. CYP2C19 polymorphisms account for inter-individual variability of drug metabolism in cynomolgus macaques.
Uno Y; Matsushita A; Shukuya M; Matsumoto Y; Murayama N; Yamazaki H
Biochem Pharmacol; 2014 Sep; 91(2):242-8. PubMed ID: 25036290
[TBL] [Abstract][Full Text] [Related]
14. Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole.
Uehara S; Uno Y; Inoue T; Kawano M; Shimizu M; Toda A; Utoh M; Sasaki E; Yamazaki H
Drug Metab Dispos; 2015 Oct; 43(10):1408-16. PubMed ID: 26228688
[TBL] [Abstract][Full Text] [Related]
15. Human plasma concentrations of cytochrome P450 probe cocktails extrapolated from pharmacokinetics in mice transplanted with human hepatocytes and from pharmacokinetics in common marmosets using physiologically based pharmacokinetic modeling.
Utoh M; Suemizu H; Mitsui M; Kawano M; Toda A; Uehara S; Uno Y; Shimizu M; Sasaki E; Yamazaki H
Xenobiotica; 2016 Dec; 46(12):1049-1055. PubMed ID: 26916082
[TBL] [Abstract][Full Text] [Related]
16. Human plasma concentrations of five cytochrome P450 probes extrapolated from pharmacokinetics in dogs and minipigs using physiologically based pharmacokinetic modeling.
Shida S; Yamazaki H
Xenobiotica; 2016 Sep; 46(9):759-64. PubMed ID: 26652678
[TBL] [Abstract][Full Text] [Related]
17. Polymorphic cytochromes P450 in non-human primates.
Uno Y; Uehara S; Yamazaki H
Adv Pharmacol; 2022; 95():329-364. PubMed ID: 35953160
[TBL] [Abstract][Full Text] [Related]
18. Utility of non-human primates in drug development: Comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes.
Uno Y; Uehara S; Yamazaki H
Biochem Pharmacol; 2016 Dec; 121():1-7. PubMed ID: 27318253
[TBL] [Abstract][Full Text] [Related]
19. In vivo individual variations in pharmacokinetics of efavirenz in cynomolgus monkeys genotyped for cytochrome P450 2C9.
Iwasaki K; Kitsugi Y; Ikeda K; Yoshikawa T; Hosaka S; Uehara S; Uno Y; Utoh M; Yamazaki H
Biopharm Drug Dispos; 2016 Sep; 37(6):379-83. PubMed ID: 27417918
[TBL] [Abstract][Full Text] [Related]
20. Modeled Hepatic/Plasma Exposures of Omeprazole Prescribed Alone in Cytochrome P450 2C19 Poor Metabolizers Are Likely Associated with Hepatic Toxicity Reported in a Japanese Adverse Event Database.
Adachi K; Ohyama K; Tanaka Y; Murayama N; Shimizu M; Saito Y; Yamazaki H
Biol Pharm Bull; 2024; 47(5):1028-1032. PubMed ID: 38797695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
